213 related articles for article (PubMed ID: 25798955)
1. [Patients treated with micafungin during their stay in intensive care unit].
Álvarez-Lerma F; Grau S; López C; Jiménez JD; Trasmonte MV; Nieto M; Parra G; Herrero E;
Med Intensiva; 2015 Nov; 39(8):467-76. PubMed ID: 25798955
[TBL] [Abstract][Full Text] [Related]
2. A practice-based observational study on the use of micafungin in Surgical Critical Care Units.
Maseda E; García-Bernedo CA; Frías I; Navarro JA; Rico J; Iranzo R; Granizo JJ; Villagrán MJ; Samsó E; Gilsanz F;
Rev Esp Quimioter; 2015 Jun; 28(3):132-8. PubMed ID: 26032997
[TBL] [Abstract][Full Text] [Related]
3. [Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the intensive care units].
Álvarez Lerma F; Olaechea Astigarraga P; Palomar Martínez M; Rodríguez Carvajal M; Machado Casas JF; Jiménez Quintana MM; Esteve Urbano F; Ballesteros Herráez JC; Zavala Zegarra E;
Med Intensiva; 2015 Apr; 39(3):149-59. PubMed ID: 24713089
[TBL] [Abstract][Full Text] [Related]
4. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
[TBL] [Abstract][Full Text] [Related]
6. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
[TBL] [Abstract][Full Text] [Related]
7. [Experience of micafungin in patients requiring extrarenal depuration].
Alvarez-Lerma F; Grau S; Díaz Y; Fernández J
Rev Esp Quimioter; 2010 Dec; 23(4):184-9. PubMed ID: 21191556
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological study of Clostridium difficile infection in critical patients admitted to the Intensive Care Unit.
Alvarez-Lerma F; Palomar M; Villasboa A; Amador J; Almirall J; Posada MP; Catalan M; Pascual C;
Med Intensiva; 2014 Dec; 38(9):558-66. PubMed ID: 24503331
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of patients admitted to Spanish ICU: A prospective observational study from the ENVIN-HELICS registry (2006-2011).
Olaechea PM; Álvarez-Lerma F; Palomar M; Gimeno R; Gracia MP; Mas N; Rivas R; Seijas I; Nuvials X; Catalán M;
Med Intensiva; 2016 May; 40(4):216-29. PubMed ID: 26456793
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of micafungin sodium on fungal infection in critical care].
Tateishi Y; Hirasawa H; Oda S; Nakanishi K; Kitamura S; Aikawa N
Nihon Ishinkin Gakkai Zasshi; 2006; 47(4):293-7. PubMed ID: 17086162
[TBL] [Abstract][Full Text] [Related]
11. The effect of positive balance on the outcomes of critically ill noncardiac postsurgical patients: a retrospective cohort study.
Shim HJ; Jang JY; Lee SH; Lee JG
J Crit Care; 2014 Feb; 29(1):43-8. PubMed ID: 24140168
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.
Saliba F; Pascher A; Cointault O; Laterre PF; Cervera C; De Waele JJ; Cillo U; Langer RM; Lugano M; Göran-Ericzon B; Phillips S; Tweddle L; Karas A; Brown M; Fischer L; ;
Clin Infect Dis; 2015 Apr; 60(7):997-1006. PubMed ID: 25520332
[TBL] [Abstract][Full Text] [Related]
13. [Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006-2010].
Olaechea-Astigarraga PM; Alvarez-Lerma F; Palomar-Martínez M; Insausti-Ordeñana J; López-Pueyo MJ; Seijas-Betolaza I; Otal-Entraigas JJ; Gimeno-Costa R; Gracia-Arnillas MP;
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):435-40. PubMed ID: 22463989
[TBL] [Abstract][Full Text] [Related]
14. Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B.
Dupont BF; Lortholary O; Ostrosky-Zeichner L; Stucker F; Yeldandi V
Crit Care; 2009; 13(5):R159. PubMed ID: 19804626
[TBL] [Abstract][Full Text] [Related]
15. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment.
Alvarez-Lerma F; Soriano MC; Rodríguez M; Catalán M; Llorente AM; Vidart N; Garitacelaya M; Maraví E; Fernández E; Alvarado F; López M; Alvarez-Sánchez B; Espinosa J; Quintana E;
Rev Esp Quimioter; 2012 Sep; 25(3):206-15. PubMed ID: 22987267
[TBL] [Abstract][Full Text] [Related]
16. [Comparison between micafungin and caspofungin for the empirical treatment of severe intra-abdominal infections in surgical intensive care patients].
Yan T; Li SL; Wang DX
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(29):2301-6. PubMed ID: 27524185
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm.
Aikawa N; Kusachi S; Oda S; Takesue Y; Tanaka H
J Infect Chemother; 2009 Aug; 15(4):219-27. PubMed ID: 19688240
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of risk factors of prolonged intensive care unit stay of critically ill obstetric patients: a 5-year retrospective review in 3 hospitals in Beijing].
Lin Y; Zhu X; Liu F; Zhao YY; Du J; Yao GQ; Li WX; Jia XJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):449-53. PubMed ID: 21878165
[TBL] [Abstract][Full Text] [Related]
19. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
[TBL] [Abstract][Full Text] [Related]
20. Mortality and functional status at one-year of follow-up in elderly patients with prolonged ICU stay.
Pintado MC; Villa P; Luján J; Trascasa M; Molina R; González-García N; de Pablo R
Med Intensiva; 2016; 40(5):289-97. PubMed ID: 26706825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
